MARKET

PBE

PBE

Invesco Biotechnology & Genome ETF
NYSEARCA
70.10
+0.85
+1.22%
Closed 15:59 07/25 EDT
OPEN
69.42
PREV CLOSE
69.25
HIGH
70.70
LOW
69.42
VOLUME
9.83K
TURNOVER
0
52 WEEK HIGH
70.70
52 WEEK LOW
52.44
TOTAL ASSET
267.88M
YTD YIELD
9.18%
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBE last week (0715-0719)?
Weekly Report · 4d ago
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 07/17 08:42
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
NASDAQ · 07/16 10:20
Weekly Report: what happened at PBE last week (0708-0712)?
Weekly Report · 07/15 09:47
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
NASDAQ · 07/12 10:20
Weekly Report: what happened at PBE last week (0701-0705)?
Weekly Report · 07/08 09:47
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
Midyear Equity Outlook - Investing Beyond The Megacaps
Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.
Seeking Alpha · 07/03 12:00
More
Profile
Fund Name
Invesco Biotechnology & Genome ETF
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco Capital Management LLC
Custodian
Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi